Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
All LSBio Custom kits have been predesigned and all necessary components, including antibodies and standards have been identified. Upon receiving a custom kit order, the kit will be assembled and quality control tested before being shipped out. Kit assembly and testing typically takes 4 to 6 weeks. In most cases the final kit is based on the Sandwich assay principle, with a few being Competitive EIA based. Specifications such as Range, Sensitivity, and Precision are defined upon completion. In the event that the custom kit cannot be successfully developed with 6 weeks of the order date, the customer will be notified and the order canceled at no cost.
F7 / Factor VII
LS-F42445 is a 96-well enzyme-linked immunosorbent assay (ELISA) for the Quantitative detection of Monkey F7 / Factor VII. It is based upon a Custom assay principle and can be used to detect levels of F7 / Factor VII as low as 0.188 nanograms per millilter.
F7 ElisaKit, Coagulation factor VII ElisaKit, Eptacog alfa ElisaKit, F7 Deficiency ElisaKit, Factor 7 ElisaKit, Factor VIIa ElisaKit, FVII coagulation protein ElisaKit, Factor VII ElisaKit, FVII ElisaKit, SPCA ElisaKit, Factor VII Deficiency ElisaKit, Proconvertin ElisaKit
F7 / Factor VII is coagulation factor VII which is a vitamin K-dependent factor essential for hemostasis. This factor circulates in the blood in a zymogen form, and is converted to an active form by either factor IXa, factor Xa, factor XIIa, or thrombin by minor proteolysis. Upon activation of the factor VII, a heavy chain containing a catalytic domain and a light chain containing 2 EGF-like domains are generated, and two chains are held together by a disulfide bond.